Cargando…

A universal monoclonal antibody protects against all influenza A and B viruses by targeting a highly conserved epitope in the viral neuraminidase

Detalles Bibliográficos
Autores principales:	Doyle, Tracey M, Hashem, Anwar M, Li, Changgui, Bucher, Doris J, Van Domselaar, Gary, Wang, Junzhi, Cyr, Terry, Farnsworth, Aaron, He, Runtao, Hurt, Aeron C, Brown, Earl G, Li, Xuguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075755/ http://dx.doi.org/10.1186/1471-2164-15-S2-P8

Ejemplares similares

Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases
por: Hashem, Anwar M., et al.
Publicado: (2009)

Correction: Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases
por: Hashem, Anwar M., et al.
Publicado: (2013)

Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines
por: Xu, Kangwei, et al.
Publicado: (2018)

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
por: Leang, Sook-Kwan, et al.
Publicado: (2017)

A Novel Synthetic Receptor-Based Immunoassay for Influenza Vaccine Quantification
por: Hashem, Anwar M., et al.
Publicado: (2013)

A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines
por: Zhao, Hui, et al.
Publicado: (2018)

Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine
por: Russell, Marsha S., et al.
Publicado: (2019)

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes
por: Wohlbold, Teddy John, et al.
Publicado: (2017)

Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies
por: Kirkpatrick Roubidoux, Ericka, et al.
Publicado: (2022)

Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action
por: Abbadi, Nada, et al.
Publicado: (2023)

Topological N-glycosylation and site-specific N-glycan sulfation of influenza proteins in the highly expressed H1N1 candidate vaccines
por: She, Yi-Min, et al.
Publicado: (2017)

Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context
por: Moss, Robert, et al.
Publicado: (2016)

Surface modifications of influenza proteins upon virus inactivation by β-propiolactone*
por: She, Yi-Min, et al.
Publicado: (2013)

PD-1 of Sigmodon hispidus: Gene identification, characterization and preliminary evaluation of expression in inactivated RSV vaccine-induced enhanced respiratory disease
por: Muralidharan, Abenaya, et al.
Publicado: (2019)

Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection
por: Muralidharan, Abenaya, et al.
Publicado: (2018)

Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution
por: Farrukee, Rubaiyea, et al.
Publicado: (2022)

Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine
por: Li, Changgui, et al.
Publicado: (2015)

Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase
por: Kirkpatrick Roubidoux, Ericka, et al.
Publicado: (2021)

Study of immunogenicity of recombinant proteins based on hemagglutinin and neuraminidase conservative epitopes of Influenza A virus
por: Dukhovlinov, Ilya, et al.
Publicado: (2013)

Susceptibility of influenza viruses circulating in Western Saudi Arabia to neuraminidase inhibitors
por: Tolah, Ahmed M., et al.
Publicado: (2016)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014
por: Takashita, Emi, et al.
Publicado: (2015)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016
por: Gubareva, Larisa V., et al.
Publicado: (2017)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012–2013
por: Meijer, Adam, et al.
Publicado: (2014)

Monoclonal antibodies targeting the influenza virus N6 neuraminidase
por: Strohmeier, Shirin, et al.
Publicado: (2022)

Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt
por: Moharam, Ibrahim, et al.
Publicado: (2021)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015
por: Hurt, Aeron C., et al.
Publicado: (2016)

Identification of a potential neutralizing linear epitope of hemagglutinin-neuraminidase in Newcastle disease virus
por: Jin, Zhongyuan, et al.
Publicado: (2021)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017
por: Lackenby, Angie, et al.
Publicado: (2018)

Mammalian Two-Hybrid Assay for Detecting Protein-Protein Interactions in Vivo
por: He, Runtao, et al.
Publicado: (2008)

GOmotif: A web server for investigating the biological role of protein sequence motifs
por: Bristow, Franklin, et al.
Publicado: (2011)

Bioactivity Determination of Native and Variant Forms of Therapeutic Interferons
por: Larocque, Louise, et al.
Publicado: (2011)

Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes
por: Vaidya, Sunil R., et al.
Publicado: (2016)

Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice
por: Muralidharan, Abenaya, et al.
Publicado: (2022)

The molecular determinants governing the immunogenicity of Japanese encephalitis live attenuated vaccines
por: Li, Yuhua, et al.
Publicado: (2017)

In silico epitope-based vaccine design against influenza a neuraminidase protein: Computational analysis established on B- and T-cell epitope predictions
por: Almalki, Shaia, et al.
Publicado: (2022)

Antiviral Therapy for the Next Influenza Pandemic
por: Hurt, Aeron C.
Publicado: (2019)

Human autoantibody-reactive epitopes of SS-B/La are highly conserved in comparison with epitopes recognized by murine monoclonal antibodies
Publicado: (1987)

Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility
por: Farrukee, R., et al.
Publicado: (2018)

HLA Epitopes: The Targets of Monoclonal and Alloantibodies Defined
por: El-Awar, Nadim, et al.
Publicado: (2017)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_27j4to9r2bil1n0oqkl1pffnn9